DrugPatentWatch Database Preview
Litigation Details for Biogen International GMBH v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2017)
» See Plans and Pricing
Biogen International GMBH v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2017)
Docket | Start Trial | Date Filed | 2017-06-30 |
Court | District Court, N.D. West Virginia | Date Terminated | 2020-06-22 |
Cause | 35:271 Patent Infringement | Assigned To | Irene Patricia Murphy Keeley |
Jury Demand | None | Referred To | James P. Mazzone |
Parties | BIOGEN INTERNATIONAL GMBH | ||
Patents | 10,029,015; 6,509,376; 6,926,907; 7,320,999; 7,619,001; 7,803,840; 8,013,002; 8,399,514; 8,759,393; 9,018,017; 9,024,096 | ||
Attorneys | David L. Anstaett | ||
Firms | Perkins Coie LLP Washington Dc | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Biogen International GMBH v. Mylan Pharmaceuticals Inc.
Biologic Drugs cited in Biogen International GMBH v. Mylan Pharmaceuticals Inc.
The biologic drugs covered by the patents cited in this case are Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , and Start Trial .
Details for Biogen International GMBH v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2017-06-30 | 1 | Complaint | “the ‘999 patent”), 7,619,001 (“the ‘001 patent”), 7,803,840 (“the ‘840 patent”), 8,759,393 (“the ‘393…- 376 Patent, # 2 Exhibit B - 999 Patent, # 3 Exhibit C - 001 Patent, # 4 Exhibit D - 840 Patent, # 5 …is an action for patent infringement of U.S. Patent Nos. 6,509,376 (“the ‘376 patent”), 7,320,999 (“the…393 patent”) and 8,399,514 (“the ‘514 patent”) arising under the patent laws of the United States, Title…5 Exhibit E - 393 Patent, # 6 Exhibit F - 514 Patent, # 7 Civil Cover Sheet)(lmm) (Entered: 06/30/2017 | External link to document |
2018-10-12 | 142 | Status Report | infringement of U.S. Patent Nos. 6,509,376 (“the ’376 patent”), 7,320,999 (“the ’999 patent”), 7,619,001 … (“the ’001 patent”), 7,803,840 (“the ’840 patent”), 8,759,393 (“the ’393 patent”) and 8,399,514 … the patents-in-suit. The ’393 patent has expired. It is Mylan’s position that this patent should be…partes review (“IPR”) of Biogen’s ’514 patent. Biogen’s Patent Owner’s Preliminary Response is due on…for regulatory patent term extension (“PTE”) on the ’376, ’999, ’001, and ’840 patents. Under the relevant | External link to document |
2019-02-05 | 196 | Stipulation and Order | affirmative defenses related to U.S. Patent Nos. 6,509,376; 7,320,999; 7,803,840; and 8,759,393. The parties…counterclaims and affirmative defenses as to U.S. Patent Nos. 7,619,001 and 8,399,514. Signed by Senior …2017 22 June 2020 1:17-cv-00116 835 Patent - Abbreviated New Drug Applications (ANDA) | External link to document |
2019-10-08 | 288 | Order | Parties to this patent infringement case involving U.S. Patent Nos. 8,399,514 (“the °514 patent”) and 7,619,001… 15-16 of the °514 patent and claims 1-3, 6-9, 12-19, and 22-24 of the *001 patent under 35 U.S.C. § 271…and 15-16 of the 514 patent and claims 1-3, 6-9, 12-19, and 22-24 of the °001 patent are not invalid and…7,619,001 (‘the 001 patent”); WHEREAS the Parties wish to narrow the issues in this litigation; WHEREAS…that it will not assert claims 17-19 of the 514 patent against Mylan (see ECF 102); THEREFORE, IT IS | External link to document |
2020-01-02 | 299 | Notice (Other) | Rajendra Kumar Joshi; Hans- 6,509,376 1/21/03 United…invalidate U.S. Patent Nos. 7,619,001 (“the ’001 patent”) and 8,399, 514 (“the ’514 patent”) (collectively… the “patents-in-suit”) and/or show the state of the art relative to the asserted patents. … Patents and File Histories Date of Issue/ Patent/Patent… Date of Issue/ Patent/Patent Publication Country of Publication | External link to document |
2020-01-08 | 308 | Other Document | 13:23-14:12 21:15-17 22:10-14 28:10-29:15 29:19-23 30:13-18 30:20-31:19 …2017 22 June 2020 1:17-cv-00116 835 Patent - Abbreviated New Drug Applications (ANDA) | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |